Abstract:Purpose: A dual-regulated adenovirus variant CNHK500, in which human telomerase reverse transcriptase promoter drove the adenovirus 5 (Ad5) E1a gene and hypoxia-response promoter controlled the E1b gene, was engineered. This virus has broad anticancer spectrum and higher specificity compared with mono-regulated adenovirus CNHK300. The objective of the current study is to show its antitumor selectivity and therapeutic potential.Experimental Design: The antitumor specificity of human telomerase reverse transcriptase and hypoxia response promoters was evaluated in a panel of tumor and normal cells. Under the control of these promoters, the tumor-selective expression of E1a and E1b genes was evaluated. Further in vitro antitumor specificity and potency of this virus were characterized by viral replication and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Subsequently, hepatocellular carcinoma xenografts were established to evaluate CNHK500 antitumor efficacy in vivo by different routes of virus administration and different dosages.Results: Human telomerase reverse transcriptase and hypoxia response promoters were activated in a tumor-selective manner or under hypoxia treatment in a broad panel of cells. Selective adenoviral early gene expression, efficient viral replication, and oncolysis were observed in all tested cancer cells with more attenuated replication capacity in normal cells. Significant regression of hepatocellular carcinoma xenografts and prolonged survival were observed by either i.t. or i.v. administration.Conclusions: CNHK500 greatly reduced side effects in normal cells via dual control of adenoviral essential genes while still preserving potent antitumor efficacy on broad-spectrum cancer cells in vitro and in vivo. It can be used as a powerful therapeutic agent not only for liver cancers but also for other solid tumors.

Adenovirus-mediated HCCS1 overexpression elicits a potent antitumor efficacy on human colorectal cancer and hepatoma cells both in vitro and in vivo

[Tumor-Targeting Expression of a New Tumor Suppressor Gene HCCS1 and Its Tumor-Selective Inhibitory Effects on Hepatocellular Carcinoma].

Potent Anti-Hepatoma Efficacy of HCCS1 Via Dual Tumor-Targeting Gene-Virotherapy Strategy.

Bc047440 Antisense Eukaryotic Expression Vectors Inhibited Hepg(2) Cell Proliferation and Suppressed Xenograft Tumorigenicity

Synergistic suppression effect on tumor growth of hepatocellular carcinoma by combining oncolytic adenovirus carrying XAF1 with cisplatin

Adenovirus-mediated Tissue-Specific Cytosine Deaminase Gene Therapy for Human Hepatocellular Carcinoma with Different AFP Expression Levels.

HCCS1 Overexpression Induces Apoptosis Via Cathepsin D and Intracellular Calcium, and HCCS1 Disruption in Mice Causes Placental Abnormality

Antiangiogenesis Gene Armed Tumor‐targeting Adenovirus Yields Multiple Antitumor Activities in Human HCC Xenografts in Nude Mice

Oncolytic Adenovirus-Mediated E1A Gene Therapy Induces Tumor-Cell Apoptosis and Reduces Tumor Angiogenesis Leading to Inhibition of Hepatocellular Carcinoma Growth in Animal Model

Increased Safety With Preserved Antitumoral Efficacy On Hepatocellular Carcinoma With Dual-Regulated Oncolytic Adenovirus

Enhanced Inhibitory Effect and Mechanisms of Adenovirus-Mediated Hepatocellular Carcinoma Supressor Gene 1 Combined with 5-FU on Growth of LoVo Cells

Adenovirus-expressed human hyperplasia suppressor gene induces apoptosis in cancer cells.

Combined Use of Chemotherapeutics and Oncolytic Adenovirus in Treatment of AFP-expressing Hepatocellular Carcinoma

An oncolytic adenovirus regulated by a radiation-inducible promoter selectively mediates hSulf-1 gene expression and mutually reinforces antitumor activity of I131-metuximab in hepatocellular carcinoma.

Oncolytic Vaccinia Virus Inhibits Human Hepatocellular Carcinoma Mhcc97-H Cell Proliferation Via Endoplasmic Reticulum Stress, Autophagy and Wnt Pathways

Adenovirus-delivered CIAPIN1 small interfering RNA inhibits HCC growth in vitro and in vivo.

Cell-Specific Expression of Artificial Micrornas Targeting Essential Genes Exhibit Potent Antitumor Effect on Hepatocellular Carcinoma Cells

Conditionally Replicative Adenovirus Vector Carrying Trail Gene For Enhanced Oncolysis Of Human Hepatocellular Carcinoma

Adenovirus-Mediated Il-24 Expression Suppresses Hepatocellular Carcinoma Growth Via Induction of Cell Apoptosis and Cycling Arrest and Reduction of Angiogenesis

Hsg Provides Antitumor Efficacy On Hepatocellular Carcinoma Both In Vitro And In Vivo

Adenovirus-Mediated Combined Anti-Angiogenic and Pro-Apoptotic Gene Therapy Enhances Antitumor Efficacy in Hepatocellular Carcinoma